With clinical trials becoming more complex, finding ways to streamline and automate laboratory processes is vital when analyzing bioanalytical samples.
As the chief scientific officer of large-molecule bioanalysis, Dr. Tom Zhang leverages his expertise to promote ever-evolving automation technologies. He also maintains Worldwide’s knowledge of large-molecule bioanalytical methodologies.
He explains that today’s bioanalytical labs are moving towards integrating automation to enhance accuracy and efficiency:
